BioWorld

Aug. 3, 2009

View Archived Issues

Study Shows Mechanism Behind Allergy-Promoting TH2 Bias

House Panel Supports 12 Years Data Exclusivity, CER Limits

Cethromycin Pact Likely Waits as FDA Wants New CAP Trial

Other News To Note

Earnings Roundup

Clinic Roundup

So Much for Summer Slump: July Financings Keep Pace

While biotech financing lagged in the first quarter, activity picked up in the second quarter, and it looks as if the third quarter is off to a fairly decent start. (BioWorld Today) Read More

FDA Clears Anadys HCV Study; Good Data Could Lure Partner

Today's news in brief

BioWorld

BioWorld briefs for June 11, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

New 5-HT2C receptor agonists reported in Hansoh patent

BioWorld Science

Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...